KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Debt to Equity (2018 - 2025)

Twist Bioscience (TWST) has disclosed Debt to Equity for 6 consecutive years, with $0.03 as the latest value for Q4 2025.

  • Quarterly Debt to Equity changed 0.03% to $0.03 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.03 through Dec 2025, changed 0.03% year-over-year, with the annual reading at $0.03 for FY2025, N/A changed from the prior year.
  • Debt to Equity for Q4 2025 was $0.03 at Twist Bioscience, up from $0.03 in the prior quarter.
  • The five-year high for Debt to Equity was $0.03 in Q1 2025, with the low at $0.0 in Q3 2021.
  • Average Debt to Equity over 3 years is $0.02, with a median of $0.03 recorded in 2025.
  • Peak annual rise in Debt to Equity hit 133.77% in 2021, while the deepest fall reached 81.03% in 2021.
  • Over 3 years, Debt to Equity stood at $0.01 in 2021, then surged by 126.83% to $0.03 in 2024, then dropped by 0.03% to $0.03 in 2025.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.03, $0.03, and $0.03 for Q4 2025, Q3 2025, and Q2 2025 respectively.